Compass TherapeuticsCMPX
13F holders, Q1 2024 (March 31)78holders
3famous investors
$1.98avg. 13F price*
At the end of Q1 2024, 78 institutions reported holding Compass Therapeutics Inc. (CMPX) in their 13F filings. The largest holders were Orbimed Advisors LLC ($44.3M), Adage Capital Partners Gp, L.L.C. ($22.0M) and Janus Henderson Group PLC ($12.8M). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Compass Therapeutics Inc.
- CUSIP
- 20454B104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $22.0M |
| Exits | 8 | $5.0M |
Ownership 78 holders
| Orbimed Advisors LLC | 0.81% | No change | 22,362,850 | $44.3M |
| Adage Capital Partners Gp, L.L.C. | 0.04% | Add +12.7% | 11,130,000 | $22.0M |
| Janus Henderson Group PLC | 0.01% | Reduce -0.8% | 6,492,900 | $12.8M |
| Blackstone Inc. | 0.05% | No change | 6,189,551 | $12.3M |
| BlackRock Inc. | 0.00% | Reduce -3.0% | 6,032,466 | $11.9M |
| Cormorant Asset Management, LP | 0.49% | New | 5,560,300 | $11.0M |
| Rock Springs Capital Management LP | 0.28% | No change | 5,513,788 | $10.9M |
| FMR LLC | 0.00% | Reduce -0.8% | 4,515,137 | $8.9M |
| Vanguard Group Inc. | 0.00% | Add +1.7% | 4,152,197 | $8.2M |
| Vivo Capital, LLC | 0.55% | No change | 3,556,023 | $7.0M |
| Opaleye Management Inc. | 1.38% | New | 3,170,000 | $6.3M |
| Blue Owl Capital Holdings LP | 1.12% | No change | 2,829,712 | $5.6M |
| Geode Capital Management, LLC | 0.00% | Add +4.2% | 2,075,335 | $4.1M |
| MPM Bioimpact LLC | 0.63% | New | 1,971,402 | $3.9M |
| State Street Corp. | 0.00% | Add +5.8% | 1,826,177 | $3.6M |
| Baker Bros. Advisors LP | 0.04% | No change | 1,557,630 | $3.1M |
| Northern Trust Corp. | 0.00% | Add +0.9% | 766,911 | $1.5M |
| Monashee Investment Management LLC | 0.12% | No change | 500,000 | $990K |
| Wellington Management Group LLP | 0.00% | New | 320,621 | $635K |
| CM Management, LLC | 0.52% | Add +148.0% | 310,000 | $614K |
| Nuveen Asset Management, LLC | 0.00% | No change | 304,504 | $603K |
| Bank of New York Mellon Corp | 0.00% | Reduce -6.9% | 252,505 | $500K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Add +13.1% | 240,800 | $477K |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -2.4% | 240,195 | $476K |
| Pennant Investors, LP | 0.11% | No change | 199,000 | $394K |
| Millennium Management | 0.00% | Reduce -60.8% | 193,767 | $384K |
| Morgan Stanley | 0.00% | Reduce -28.0% | 164,231 | $325K |
| Exchange Traded Concepts, LLC | 0.01% | Add +123.2% | 146,874 | $291K |
| Citadel Advisors | 0.00% | Reduce -13.2% | 144,185 | $285K |
| Two Sigma Investments, LP | 0.00% | Reduce -26.5% | 141,642 | $280K |
| Pale Fire Capital SE | 0.03% | Reduce -30.4% | 125,968 | $249K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -40.6% | 122,712 | $243K |
| Rhumbline Advisers | 0.00% | Add +2.5% | 119,474 | $237K |
| DAFNA Capital Management LLC | 0.05% | No change | 116,882 | $231K |
| UBS Group AG | 0.00% | Add +7.5% | 110,211 | $218K |
| Barclays PLC | 0.00% | Reduce -39.5% | 75,913 | $150K |
| Renaissance Technologies | 0.00% | Reduce -60.2% | 70,400 | $139K |
| Two Sigma Advisers, LP | 0.00% | Reduce -16.2% | 59,300 | $117K |
| Squarepoint Ops LLC | 0.00% | Reduce -42.7% | 50,812 | $101K |
| MetLife Investment Management, LLC | 0.00% | Add +1.2% | 50,530 | $100K |
| B. Riley Wealth Advisors, Inc. | 0.00% | No change | 50,000 | $99K |
| Bank of America Corp. | 0.00% | Reduce -50.4% | 45,414 | $90K |
| American International Group, Inc. | 0.00% | Reduce -0.8% | 44,974 | $89K |
| Caxton Corp. | 0.49% | No change | 43,465 | $86K |
| Deutsche Bank AG | 0.00% | Reduce -4.3% | 42,688 | $85K |
| Invesco Ltd. | 0.00% | Reduce -3.3% | 41,763 | $83K |
| Bleakley Financial Group, LLC | 0.00% | New | 40,243 | $80K |
| Simplicity Wealth,LLC | 0.00% | New | 40,243 | $80K |
| Manufacturers Life Insurance Company, The | 0.00% | Add +2.3% | 38,386 | $76K |
| JPMorgan Chase & Co. | 0.00% | Reduce -38.5% | 38,353 | $76K |
| New York State Common Retirement Fund | 0.00% | Reduce -0.3% | 38,077 | $75K |
| Voya Investment Management LLC | 0.00% | Reduce -18.6% | 32,198 | $64K |
| Wells Fargo & Company | 0.00% | Add +14.8% | 31,819 | $63K |
| SG Americas Securities, LLC | 0.00% | Reduce -39.6% | 28,741 | $57K |
| T. Rowe Price Associates Inc. | 0.00% | Add +3.0% | 24,055 | $48K |
| New Capital Management LP | 0.01% | No change | 21,131 | $42K |
| Jane Street Group, LLC | 0.00% | Reduce -75.1% | 20,673 | $41K |
| STRS Ohio | 0.00% | Reduce -5.8% | 17,900 | $35K |
| Citigroup Inc. | 0.00% | Add +27.2% | 17,042 | $34K |
| Algert Global LLC | 0.00% | New | 16,580 | $33K |
| ProShare Advisors LLC | 0.00% | Add +8.6% | 16,396 | $32K |
| Alliancebernstein L.P. | 0.00% | No change | 13,480 | $27K |
| Dimensional Fund Advisors LP | 0.00% | No change | 11,117 | $22K |
| Principal Financial Group Inc. | 0.00% | Reduce -11.6% | 10,586 | $21K |
| HSBC Holdings PLC | 0.00% | Reduce -67.4% | 10,476 | $21K |
| ADAR1 Capital Management, LLC | 0.01% | New | 10,206 | $20K |
| Victory Capital Management Inc. | 0.00% | Reduce -9.2% | 10,021 | $20K |
| California State Teachers Retirement System | 0.00% | Reduce -38.9% | 9,176 | $18K |
| Legal & General Group Plc | 0.00% | Reduce -63.5% | 7,867 | $16K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 7,536 | $15K |
| Amalgamated Bank | 0.00% | Reduce -63.6% | 3,077 | $6K |
| Royal Bank of Canada | 0.00% | Reduce -92.9% | 2,070 | $4K |
| Metropolitan Life Insurance Co | 0.00% | Add +71.7% | 1,926 | $4K |
| Federated Hermes, Inc. | 0.00% | Reduce -73.7% | 933 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -92.2% | 797 | $2K |
| Nisa Investment Advisors, LLC | 0.00% | Reduce -69.2% | 20 | $40 |
| Avior Wealth Management, LLC | 0.00% | New | 16 | $31 |
| Cwm, LLC | 0.00% | Add +1.9% | 161 | $0 |
"% of holder's portfolio" is CMPX's weight in each manager's 13F, not the share of Compass Therapeutics Inc. the manager owns.